New drug combo aims to shrink tumors before stomach cancer surgery

NCT ID NCT06576921

Summary

This study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy before surgery is more effective for treating locally advanced stomach or gastroesophageal junction cancer. Researchers will compare the new combination to chemotherapy alone in 116 participants to see if it leads to more complete tumor removal and better long-term outcomes. The main goal is to see if the drug combo helps eliminate all signs of cancer in the tissue removed during surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STOMACH NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Digestive surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi' an, China

    RECRUITING

    Xi'an, Shaanxi, 710032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of General Surgery, Tangdu Hospital, Air Force Medical University

    RECRUITING

    Xi'an, Shaanxi, 710032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The fourth hospital of Hebei Medical University

    RECRUITING

    Shijiazhuang, Heibei Province, 050000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, 300060, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.